| Issue Date | Title | Author(s) |
| 2017-11-21 | Targeting the master regulator mTOR: A new approach to prevent the neurological of consequences of parasitic infections? | Donnelly, S; Huston, WM; Johnson, M; Tiberti, N; Saunders, B; O'Brien, B; Burke, C; Labbate, M; Combes, V |
| 2009-12-11 | The role and regulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury. | Fan, X; Heijnen, CJ; van der Kooij, MA; Groenendaal, F; van Bel, F |
| 2019-03-01 | Citrulline protects mice from experimental cerebral malaria by ameliorating hypoargininemia, urea cycle changes and vascular leak | Gramagliaid, I; Velez, J; Chang, YS; Caparros-Wanderley, W; Combes, V; Grau, G; Stins, MF; Van Der Heyde, HC |
| 2016-01-01 | Cryptococcal transmigration across a model brain blood-barrier: Evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. grubii strain H99 and Cryptococcus gattii strain R265 | Sorrell, TC; Juillard, PG; Djordjevic, JT; Kaufman-Francis, K; Dietmann, A; Milonig, A; Combes, V; Grau, GER |
| 2022-04-22 | Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy. | Zou, Y; Sun, X; Yang, Q; Zheng, M; Shimoni, O; Ruan, W; Wang, Y; Zhang, D; Yin, J; Huang, X; Tao, W; Park, JB; Liang, X-J; Leong, KW; Shi, B |
| 2019 | Upconversion Nanoparticle-Based Strategy for Crossing the Blood-Brain Barrier to Treat the Central Nervous System Disease. | Fu, L; Chung, R; Shi, B |
| 2022-07-15 | Aspect Ratio of PEGylated Upconversion Nanocrystals Affects the Cellular Uptake In Vitro and In Vivo. | Fu, L; Shi, B; Wen, S; Morsch, M; Wang, G; Zhou, Z; Mi, C; Sadraeian, M; Lin, G; Lu, Y; Jin, D; Chung, R |
| 2016-11-01 | Delivery of Fluorescent Nanoparticles to the Brain | Shimoni, O; Shi, B; Adlard, PA; Bush, AI |
| 2021-06-03 | Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier | Li, J; Zheng, M; Shimoni, O; Banks, WA; Bush, AI; Gamble, JR; Shi, B |
| 2022-04-22 | Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy. | Zou, Y; Sun, X; Yang, Q; Zheng, M; Shimoni, O; Ruan, W; Wang, Y; Zhang, D; Yin, J; Huang, X; Tao, W; Park, JB; Liang, X-J; Leong, KW; Shi, B |
